Skip to content

Publications, events, virus pictures...

Latest news

Creation of a platform dedicated to oncolytic viruses

9 décembre 2024 |
Creation of a platform dedicated to oncolytic viruses We are pleased to announce the creation of a platform dedicated to oncolytic viruses, to accelerate the time-to-market for your oncolytic viruses,
READ MORE

NeoVirTech and VirexpR have joined forces to develop an experimental test bench model of airborne contamination by poxviruses

3 septembre 2024 |
NeoVirTech and VirexpR have joined forces to develop an experimental test bench model of airborne contamination by poxviruses “On 14 August, the WHO declared an international public health emergency in
READ MORE
NeoVirtech prélèvement

NeoVirTech will be present at the Eurosatory meeting

6 mai 2024 |
NeoVirTech will be present at the Eurosatory meeting, the global event for defence and security. Come and meet us at Hall5a to discuss MCM development and disinfection testing
READ MORE

March 2024, NeoVirTech obtains funding from the AAP France 2030 to develop innovative theranostic platform for cancer virotherapies

2 avril 2024 |
NeoVirTech obtains funding from the AAP France 2030 to develop innovative theranostic platform for cancer virotherapies. NeoVirTech, in partnership with Imactiv-3D, the ImPACT team from the Cancer Research Center of
READ MORE

February 2024, NeoVirTech celebrates its 10 years of activity.

2 février 2024 |
February 2024, NeoVirTech celebrates its 10 years of activity. We are extremely proud to announce that NeoVirTech celebrate its 10 years of activity today. We want to thanks all the
READ MORE
LOAD MORE